CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-19 | BIOTECH TARGET N V 10% owner | Purchase | +168,422 | $3.70 | $624K | 7,443,986 |
| 2022-06-15 | Karrels James SVP, CFO and Secretary | Purchase | +40,000 | $2.47 | $99K | 191,776 |
| 2022-05-23 | HEIDEN WILLIAM K Director | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2022-05-19 | STUMP DAVID C Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-05-19 | SIEGEL JAY PHILIP Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-05-19 | SIEGEL JAY PHILIP Director | Grant or award · Stock Option (right to buy) | +24,080 | 24,080 | ||
| 2022-05-19 | O'Brien Federica F. Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-05-19 | O'Brien Federica F. Director | Grant or award · Stock Option (right to buy) | +24,080 | 24,080 | ||
| 2022-05-19 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-05-19 | HURWITZ EDWARD Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-05-19 | Ferrante Karen Jean Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2022-05-19 | Ferrante Karen Jean Director | Grant or award · Stock Option (right to buy) | +20,640 | 20,640 | ||
| 2022-05-16 | Koenig Scott President and CEO | Exercise or conversion | +53,265 | $1.51 | $80K | 1,049,636 |
| 2022-05-16 | Koenig Scott President and CEO | Exercise or conversion · Employee stock option (right to buy) | −53,265 | $1.51 | $80K | 0 |
| 2022-05-14 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion | +5,000 | 116,090 | ||
| 2022-05-14 | Bonvini Ezio Sr VP, Research & CSO | Shares withheld for taxes | −1,666 | $4.16 | $7K | 114,424 |
| 2022-05-14 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion · Restricted Stock Unit | −5,000 | 0 | ||
| 2022-03-28 | Karrels James SVP, CFO and Secretary | Exercise or conversion | +8,316 | $1.51 | $13K | 151,776 |
| 2022-03-28 | Karrels James SVP, CFO and Secretary | Exercise or conversion · Employee stock option (right to buy) | −8,316 | $1.51 | $13K | 0 |
| 2022-03-04 | Risser Eric Blasius Chief Operating Officer | Exercise or conversion | +500 | $0.94 | $470 | 44,968 |
Page 21 of 26 · 503 trades